Reaktionsgleichung
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[N:13]=[CH:12][C:11]([NH2:14])=[CH:10][CH:9]=2)[CH2:4][CH2:3]1.[S:15]1[CH:19]=[C:18]([C:20]2[C:29]3[N:28]=[CH:27][CH:26]=[N:25][C:24]=3[C:23]([C:30](O)=[O:31])=[CH:22][CH:21]=2)[C:17]2[CH:33]=[CH:34][CH:35]=[CH:36][C:16]1=2>C(Cl)Cl.CO>[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[N:13]=[CH:12][C:11]([NH:14][C:30]([C:23]3[C:24]4[N:25]=[CH:26][CH:27]=[N:28][C:29]=4[C:20]([C:18]4[C:17]5[CH:33]=[CH:34][CH:35]=[CH:36][C:16]=5[S:15][CH:19]=4)=[CH:21][CH:22]=3)=[O:31])=[CH:10][CH:9]=2)[CH2:4][CH2:3]1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
The title compound was prepared in analogy to the procedure described in Step 14.1 but stirring the reaction mixture for 20 h at rt, using 6-(4-methylpiperazin-1-yl)-pyridin-3-ylamine (prepared as described in Example 33 but using N-methyl-piperazine in Step 33.2) and 8-benzo[b]thiophen-3-yl-quinoxaline-5-carboxylic acid (Example 59). Title compound: ESI-MS: 481.0 [M+H]+; tR=3.81 min (System 1); TLC: Rf=0.40 (DCM/MeOH, 9:1).
Aufarbeitung
- customThe title compound was prepared in analogy to the procedure
Quellen und Nachweise
- ORD-Eintrag
- ord-5f384e5eb4e64537bed328c7dfad81e3
- Quelldatensatz
- uspto-grants-2014_03
- Patentnummer
- US08674099B2
Verknüpfte Notizen
Wird geladen…